Unlisted
| Company Name | (주)셀로맥스사이언스 |
| English Name | Cellromax Science Co., Ltd. |
| Business Reg. No. | 1258627262 |
| CEO | 서정민 |
| Address | 경기도 용인시 기흥구 구성로 357 D동 710호 (청덕동, 용인테크노밸리) |
| Industry | 건강기능식품 제조업 |
| Industry Code | 10897 |
| Established | 20141022 |
| Phone | 031-662-1395 |
| Website | cellromax.kr/ |
| Regular Employees | 47persons |
| Corp. Reg. No. | 1313110142300 |
Venture Certified
| 기술평가보증기업(기금) | 2018-11-21 ~ 2020-11-20 | 20180113197 | 2018-11-21 |
| 기술평가보증기업(기금) | 2020-11-21 ~ 2022-11-20 | 20200114835 | 2018-11-21 |
| 혁신성장유형 | 2024-09-24 ~ 2027-09-23 | 20240924030062 | 2018-11-21 |
Revenue CAGR +1.3%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 216B | 193B | 211B |
| Operating Profit | 55B | 46B | 66B |
| Net Profit | 38B | 45B | 47B |
| Total Assets | 491B | 328B | 285B |
| Total Liabilities | 46B | 27B | 28B |
| Total Equity | 445B | 301B | 258B |
▲ 7.1%
▼ 2.0%
▼ 8.0%
▲ 4.2%
▼ 48.5%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 서정민 | 사내이사 | 경영총괄 | - |
| 김성락 | 사내이사 | 경영지원총괄 CFO | - |
| 양인규 | 사내이사 | 연구소장 | - |
| 이정규 | 사외이사 | 경영자문 | - |
| 김태훈 | 사외이사 | 경영자문 | - |
| 윤 헌 | 사외이사 | 경영자문 | - |
| 안종균 | 감사 | 감사 | - |
| 서지완 | 미등기 | 고객케어본부장 | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - |
| NPS Subscribers | 53persons |
| CEO | 서정민 |
| Est. Avg. Annual Salary | 4,18610K (34910K/mo) |
| Hired (12 mo) | +0persons |
| Left (12 mo) | -0persons |
| Net Change (12 mo) | 0persons |
| NPS Join Date | 2015-01-15 |
| Patent Title | Applicant | Application No. | Filing Date | Status |
|---|---|---|---|---|
| 돈태반 추출물을 포함하는 뇌신경계 관련 우울증 예방, 개선 또는 치료용 조성물 | 주식회사 셀로맥스사이언스 | 1020240029567 | 2024-02-29 | 공개 |
| 당귀 추출물, 작약 추출물 및 샤프란 추출물을 포함하는 여성 골다공증 예방, 개선 또는 치료용 조성물 | 주식회사 셀로맥스사이언스 | 1020210165515 | 2021-11-26 | 등록 |
| 부아메라 추출분말 및 분골 추출분말을 함유하는 면역 증진용 조성물 | 주식회사 셀로맥스사이언스 | 1020210146403 | 2021-10-29 | 등록 |
| 약국 맞춤형 광고 편성표 작성 방법 | 주식회사 셀로맥스사이언스 | 1020210115219 | 2021-08-31 | 등록 |
| 메틸설포닐메탄 및 전칠삼 복합추출물을 포함하는 조성물 | 주식회사 셀로맥스사이언스 | 1020180124154 | 2018-10-18 | 취하 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
2 Additional Data Sources
{
"address": "경기 용인시",
"ceo_name": "서정민",
"certificate": [
{
"cert_number": "20180113197",
"changes": "",
"disclosure_date": "2018-11-21",
"first_cert_date": "2018-11-21",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2018-11-21 ~ 2020-11-20"
},
{
"cert_number": "20200114835",
"changes": "",
"disclosure_date": "2020-11-16",
"first_cert_date": "2018-11-21",
"no": "2",
"type": "기술평가보증기업(기금)",
"valid_period": "2020-11-21 ~ 2022-11-20"
},
{
"cert_number": "20240924030062",
"changes": "",
"disclosure_date": "2024-09-24",
"first_cert_date": "2018-11-21",
"no": "3",
"type": "혁신성장유형",
"valid_period": "2024-09-24 ~ 2027-09-23"
}
],
"company_name": "주식회사 셀로맥스사이언스",
"financials": {
"2022": {
"capital_stock": 1030000000,
"cost_of_sales": 11232370000,
"current_assets": 13244462000,
"current_liabilities": 2609962000,
"gross_profit": 9853486000,
"net_income": 5938391000,
"net_income_bs": 4731581000,
"non_current_assets": 15285476000,
"non_current_liabilities": 154604000,
"non_operating_expenses": 1139552000,
"non_operating_income": 468318000,
"operating_profit": 6609625000,
"revenue": 21085856000,
"sga_expenses": 3243861000,
"total_assets": 28529938000,
"total_equity": 25765372000,
"total_liabilities": 2764566000
},
"2023": {
"capital_stock": 1030000000,
"cost_of_sales": 9554140000,
"current_assets": 17120422000,
"current_liabilities": 2352576000,
"gross_profit": 9755383000,
"net_income": 5655014000,
"net_income_bs": 4499300000,
"non_current_assets": 15706850000,
"non_current_liabilities": 359998000,
"non_operating_expenses": 161429000,
"non_operating_income": 1197706000,
"operating_profit": 4618737000,
"revenue": 19309523000,
"sga_expenses": 5136646000,
"total_assets": 32827272000,
"total_equity": 30114698000,
"total_liabilities": 2712574000
},
"2024": {
"capital_stock": 1164408000,
"cost_of_sales": 9345977000,
"current_assets": 30877557000,
"current_liabilities": 3154281000,
"gross_profit": 12284359000,
"net_income": 5136138000,
"net_income_bs": 3817249000,
"non_current_assets": 18222710000,
"non_current_liabilities": 1424328000,
"non_operating_expenses": 2515783000,
"non_operating_income": 2151401000,
"operating_profit": 5500520000,
"revenue": 21630336000,
"sga_expenses": 6783839000,
"total_assets": 49100267000,
"total_equity": 44521658000,
"total_liabilities": 4578609000
}
},
"industry": "건강기능식품 제조업",
"investment": [],
"phone": "031-662-****",
"source": "pg_migration"
}{
"address": "경기도 용인시 기흥구 구성로",
"brno": "125862****",
"cappedWarning": false,
"companyName": "주식회사 셀로맥스사이언스",
"estimatedAvgAnnualSalary": 41863956,
"estimatedAvgMonthlySalary": 3488663,
"fetchedAt": "2026-03-05T13:34:11.153Z",
"industryCode": "512287",
"industryName": "기타 가공식품 도매업",
"joinDate": "20150115",
"last12MonthsHired": 0,
"last12MonthsLeft": 0,
"last12MonthsNetChange": 0,
"leaveDate": null,
"monthlyPensionAmount": 17565420,
"monthlyTrend": [
{
"lostSubscribers": 0,
"newSubscribers": 0,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6754452",
"status": "1",
"styleCode": "1",
"subscriberCount": 53,
"turnoverMonths": 1
}Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | DART | Collected |
| Investment Metrics | DART | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| Venture System Detail | 2026-03-05 | Collected |
| SME Status Info | 2026-03-05 | Collected |
| nps | 2026-03-05 | Collected |
| DART Financial | 2026-02-28 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |